XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.3
Unaudited Condensed Statements of Cash Flows - USD ($)
1 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2026
Cash Flows from Operating Activities:    
Net Income (Loss) $ 1,716,907
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on cash held in Trust (2,065,245)
Change in fair value of overallotment option (212,823)
Operating costs paid by shareholder of the Sponsor in exchange for equity 7,500
Changes in assets/liabilities:    
Prepaid expenses (266,369)
Accrued expenses 233,340
Accounts payable 1,700
Net Cash Used In Operating Activities (584,990)
Cash Flows from Investing Activities:    
Cash deposited into Trust Account (157,785,000)
Net Cash Used In Investing Activities (157,785,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class A ordinary shares 157,000,000
Proceeds from issuance of private placement warrants 2,750,000
Repayment of sponsor note (86,158)
Payment of offering costs (644,679)
Net Cash Provided by Financing Activities 159,019,163
Net change in cash 649,173
Cash at beginning of period
Cash at end of period 649,173
Supplemental Schedule of Non-Cash Financing Activities:    
IPO Advisor shares issued for offering costs $ 2,000,000
Issuance of Class B ordinary shares in exchange for a payment to a vendor 25,000
Offering cost services provided by shareholder of the Sponsor that were forgiven $ 150,000 $ 90,000
Offering costs included in accrued offering costs 37,828
Deferred underwriting commission included in non cash Initial Public Offering costs 9,420,000
Remeasurement of Class A ordinary shares to redemption value 14,977,354
Initial recognition of over-allotment liability 212,823
Fair value of warrants issued as offering cost $ 1,422,185